Probiotics
Probiotics (Multi-Strain)
Beneficial live bacteria that support gut health, immune function, and may improve mood and digestion.
Probiotics are live microorganisms that provide health benefits when consumed. Different strains have different effects — Lactobacillus and Bifidobacterium are most studied. Benefits include improved digestion, enhanced immune function, and emerging evidence for mood support via the gut-brain axis. Strain selection matters significantly.
Mechanisms of Action
Microbiome Balance
Supports a healthy balance of gut bacteria
Gut Barrier Support
Strengthens the intestinal lining
Immune Modulation
Supports immune cell function in the gut
Recommended Dose
10-20 billion CFU
Optimal Timing
- With or without food (strain-dependent)
- Same time daily for consistency
Take with food
Best Form
Capsules with multiple strains
Alternatives: Powder, Fermented foods (yogurt, kefir, kimchi), Liquid
Look for products with strain-level identification (e.g., Lactobacillus rhamnosus GG). Refrigeration may extend shelf life but isn't always required.
Duration
Minimum: 4 weeks
Optimal: 8 weeks
Cycling: Not required
Note: Some strains survive better with food; others are fine on an empty stomach. Consistency matters more than timing. Check product recommendations.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Improved Digestion
Reduced bloating, gas, and irregularity
Immune Support
May reduce cold and flu frequency
Mood Improvement
Some strains may reduce anxiety and improve mood
Initial GI Symptoms
Temporary bloating or gas when starting
Generally considered safe; may even benefit infant microbiome
Consult doctor; risk of systemic infection in severe cases
Generally safe; use child-specific products
Who Should NOT Take This
- Severely immunocompromised individuals
- Central venous catheters
- Severe acute pancreatitis
Drug Interactions
Use with caution in immunocompromised individuals
Antibiotics may kill probiotic bacteria; separate doses by 2-3 hours
Possible Side Effects
Tip: Start with lower dose; usually resolves in 1-2 weeks
Tip: Reduce dose or try different strains
Warnings
- Effects are strain-specific — not all probiotics are the same
- Quality varies widely between products
- Severely ill or immunocompromised should consult a doctor
L-Glutamine
complementaryL-Glutamine supports gut lining while probiotics improve microbiome
Comprehensive gut health support
Berberine
complementaryBerberine has antimicrobial effects; probiotics restore balance
Some take probiotics after berberine course
Butyrate
complementaryProbiotics produce butyrate; supplement ensures adequate levels
Comprehensive microbiome support
Colostrum
complementaryColostrum feeds good bacteria; probiotics add more
Comprehensive gut restoration
Cranberry Extract
complementarySupports healthy urogenital flora
Multi-pathway urinary tract protection
D-Mannose
complementarySupports healthy urogenital flora
Comprehensive urinary tract protection
DGL Licorice
complementaryDGL heals lining; probiotics support microbiome
Comprehensive gut restoration
Digestive Enzymes
complementaryEnzymes break down food; probiotics support gut flora
Comprehensive digestive support
Inulin
essentialInulin feeds the beneficial bacteria that probiotics provide
Synbiotic effect - probiotics + prebiotics together
PHGG
complementaryPrebiotic feeds the probiotic bacteria
Enhanced microbiome support
Psyllium Husk
complementaryFiber feeds beneficial gut bacteria
Psyllium provides prebiotic fiber, probiotics provide beneficial bacteria
Resistant Starch
complementaryRS feeds the beneficial bacteria probiotics provide
Synbiotic effect - enhanced microbiome support
Saccharomyces Boulardii
complementaryCan be combined with bacterial probiotics
Comprehensive gut flora support
Turkey Tail
complementaryTurkey tail prebiotics feed probiotic bacteria
Synbiotic gut and immune support
Top studies from 40+ peer-reviewed papers
Liu YC et al. • International journal of molecular sciences (2022)
“We recommend the use of probiotics to prevent and treat oral mucositis during cancer therapy.”
Key Findings:
- Three trials using Lactobacilli-based probiotics reported that the incidence of oral mucositis in the probiotic group was significantly low (risk ratio [RR] = 0.84, 95% confidence interval [CI] = 0.77−0.93, p = 0.0004).
- Seven trials reported a significantly low incidence of severe oral mucositis in the probiotic group (RR = 0.65, 95% CI = 0.53−0.81, p < 0.0001).
- The requirement of enteral nutrition was significantly low in the probiotic group (odds ratio = 0.34, 95% CI: 0.13−0.92, p < 0.05).
Collinson S et al. • The Cochrane database of systematic reviews (2020)
“Probiotics probably make little or no difference to the number of people who have diarrhoea lasting 48 hours or longer, and we are uncertain whether probiotics reduce the duration of diarrhoea.”
Key Findings:
- Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
- Effect size was similar and marked heterogeneity persisted in pre-specified subgroup analyses of the primary outcomes that included all studies.
- In six trials (433 participants) of Lactobacillus reuteri, there was consistency amongst findings (I² = 0%), but risk of bias was present in all included studies.
- In addition, there were no clear differences in effect size for the primary outcomes in post hoc analyses according to decade of publication of studies and whether or not trials had been registered.
Ong TG et al. • The Cochrane database of systematic reviews (2019)
“There is no clear evidence that probiotics are more effective than placebo at preventing infantile colic; however, daily crying time appeared to reduce with probiotic use compared to placebo.”
Key Findings:
- There is no clear evidence that probiotics are more effective than placebo at preventing infantile colic; however, daily crying time appeared to reduce with probiotic use compared to placebo.
- Published in The Cochrane database of systematic reviews (2019)
- Further research warranted to confirm findings
Goldenberg JZ et al. • The Cochrane database of systematic reviews (2017)
“Based on this systematic review and meta-analysis of 31 randomized controlled trials including 8672 patients, moderate certainty evidence suggests that probiotics are effective for preventing CDAD (NNTB = 42 patients, 95% CI 32 to 58).”
Key Findings:
- A complete case analysis (i.e. participants who completed the study) among trials investigating CDAD (31 trials, 8672 participants) suggests that probiotics reduce the risk of CDAD by 60%.
- The incidence of CDAD was 1.5% (70/4525) in the probiotic group compared to 4.0% (164/4147) in the placebo or no treatment control group (RR 0.40, 95% CI 0.30 to 0.52; GRADE = moderate).
- Twenty-two of 31 trials had missing CDAD data ranging from 2% to 45%.
- Trials with a baseline CDAD risk of 0% to 2% and 3% to 5% did not show any difference in risk but trials enrolling participants with a baseline risk of > 5% for developing CDAD demonstrated a large 70% risk reduction (interaction P value = 0.01).
Asad A et al. • Nutrition reviews (2025)
“Probiotics showed substantial reductions in depression symptoms and moderate reductions in anxiety symptoms.”
Key Findings:
- Probiotics demonstrated a significant reduction in depression symptoms (SMD: -0.96; 95% CI: -1.31, -0.61) and a moderate reduction in anxiety symptoms (SMD: -0.59; 95% CI: -0.98, -0.19).
- Prebiotics did not show a significant effect on depression (SMD: -0.28; 95% CI: -0.61, 0.04).
- High heterogeneity was observed across studies, and subgroup analyses indicated that study duration and probiotic formulations contributed to the variation in effect sizes.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.